Importancia de la determinación de dimero d cómo marcador de riesgo en pacientes con covid- 19
DOI:
https://doi.org/10.23857/dc.v9i1.3108Palabras clave:
Dimero D en Covid-19, SARSCOV-2, Gravedad por hipercoagulabilidad y Dimero D, Tromboembolismo venoso, Diagnostico, Importancia Dimero DResumen
Este articulo trata sobre la importancia de la realización de rutina de Dimero D en pacientes COVID-19 y en aquellos que han superado la enfermedad mencionada, como predictor de gravedad y como marcador de secuelas respectivamente, debido a que la hipercoagulabilidad en pacientes COVID-19 es ambigua se considera que la prueba de Dimero D es un marcador global de activación de la hemostasia en pacientes que han sido infectados por el virus del SARSCOV-2 y por ende permite verificar, predecir complicaciones y secuelas, gracias a este examen de laboratorio el resultado le sirve al facultativo de la salud como guía para la instauración terapéutica y profiláctica pertinentes en pacientes con valores elevados del mismo.
Citas
Lippi G, Mullier F, Favaloro EJ. D-dimer: Old dogmas, new (COVID-19) tricks. Clin Chem Lab Med. 2022;
Ryn vanden R, Iturre VM. Utilidad clínica de la elevación del dímero-D a la admisión en pacientes Clinical utility of elevated D-dimer on admission in patients with suspected COVID-19. 29. Available from: https://www.argentina.gob.ar/salud/coro-
Patil S. Role of “Serial D-Dimer Level” in predicting Severity and outcome in COVID-19 pneumonia: A Prospective multicentric Observational Study of 1000 cases in Tertiary Care Setting in India. Eurasian J Med Adv. 2022;2(2):73–80.
Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, et al. The Role of D- Dimers in the Initial Evaluation of COVID-19 [Response To Letter]. Ther Clin Risk Manag. 2022;18(March):593–4.
Du WN, Zhang Y, Yu Y, Zhang RM. D-dimer levels is associated with severe COVID-19 infections: A meta-analysis. Int J Clin Pract. 2021;75(8):1–5.
Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, Bajracharya T, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One [Internet]. 2021;16(8 August 2021):1–13. Available from: http://dx.doi.org/10.1371/journal.pone.0256744
Mirawati DK, Budianto P, Danuaji R, Subandi S, Ristinawati I, Prabaningtyas HR. Long- COVID neurological symptoms are associated with D-dimer levels in COVID-19 patients. Universa Med. 2022;41(2):169–75.
Santos-poleo Y Dos, Pérez-sánchez L, Ocanto A. Elevated D-Dimer and acute pulmonary embolism in COVID-19 patients Introduction Chinese scientists have isolated a new coronavirus?: severe acute respiratory syndrome. J Negat no Posit results. 2020;1–12.
Lehmann A, Prosch H, Zehetmayer S, Gysan MR, Bernitzky D, Vonbank K, et al. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One [Internet]. 2021;16(10 October):1–8. Available from: http://dx.doi.org/10.1371/journal.pone.0258351
Auditeau C, Khider L, Planquette B, Sanchez O, Smadja DM, Gendron N. D-dimer testing in clinical practice in the era of COVID-19. Res Pract Thromb Haemost. 2022;6(4):1–5.
Fazio S, Tufano A, De Simone G. Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2022;48(1):115–7.
Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8(1):1–11.
Varikasuvu SR, Varshney S, Dutt N, Munikumar M, Asfahan S, Kulkarni PP, et al. D- dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies. Sci Rep [Internet]. 2021;11(1):1–11. Available from: https://doi.org/10.1038/s41598-021-01462-5
Rueda-Camino JA, Sendín-Martín V, Joya-Seijo MD, Angelina-García M, Zamarro-García C, Gimena-Rodríguez FJ, et al. Plasma D-dimer value corrected by inflammatory markers in patients with SARS-CoV-2 infection: Its prognostic value in the diagnosis of venous thromboembolism. Med Clin (Barc). 2022;158(6):265–9.
Moreno G, Carbonell R, Bodí M, Rodríguez A. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Med Intensiva. 2021;45(1):42–55.
Meisinger C, Kirchberger I, Warm TD, Hyhlik-Dürr A, Goßlau Y, Linseisen J. Elevated Plasma D-Dimer Concentrations in Adults after an Outpatient-Treated COVID-19 Infection. Viruses. 2022;14(11):2441.
Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression. Clin Appl Thromb. 2021;27.
Riley RS, Gilbert AR, Dalton JB, Pai S, McPherson RA. Widely used types and clinical applications of D-dimer assay. Lab Med. 2016;47(2):90–102.
Gonçalves FAR, Besen BAMP, Lima CA de, Corá AP, Pereira AJR, Perazzio SF, et al. Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study. Clinics. 2021;76(1):1–11.
De F, Ipadm-- MN, Editor F. iMedPub Journals Dimero-D Como Marcador de Severidad en Rafael Medina Lucero *, D-Dimer as a Marker of Severity?: Covid-19 Introduccion Resultados Metodologia. 2022;(March 2020):2020–3.
Vidali S, Morosetti D, Cossu E, Luisi MLE, Pancani S, Semeraro V, et al. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: A systematic review. ERJ Open Res [Internet]. 2020;6(2):1–10. Available from: http://dx.doi.org/10.1183/23120541.00260-2020
Düz ME, Balci A, Menek?e E. D-dimer levels and covid-19 severity: Systematic review and meta-analysis. Tuberk Toraks. 2020;68(4):353–60.
Baña TM, Cancela AM. Prognostic value of D-dimer at admission in COVID-19 patients. 2020;25:2021.
Pop C, Feren? I. High D-dimer values and post-discharge acute pulmonary embolism in young patients with COVID-19: A case series. Sanamed. 2021;16(1):85–90.
Castillo-Huerta C, Castillo-Velásquez Y, Chávez-Cerna A, Cubas-Iparraguirre A, Vergara- de la Rosa E. Dímero D como factor pronóstico de gravedad en pacientes COVID-19. Rev del Cuerpo Médico del HNAAA. 2021;13(4):459–60.
Javorac J, Živanovic D, Stojkov S, Milicic JD, Fradelos E, Savic N. COVID-19 associated pulmonary embolism with D-dimer values within the referent range: A case report and review of the literature. Eur Rev Med Pharmacol Sci. 2021;25(24):7971–5.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Lourdes Gioconda Tabares-Rosero
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors retain copyright and guarantee the Journal the right to be the first publication of the work. These are covered by a Creative Commons (CC BY-NC-ND 4.0) license that allows others to share the work with an acknowledgment of the work authorship and the initial publication in this journal.
